The accuracy of staging of lung cancer is reflected by the extent of medias
tinal lymph node sampling. The more extensively a patient is tested, the mo
re likely there will be the accurate N-stage diagnosed. Adequate lymph node
dissection during surgery for lung cancer therefore requires complete diss
ection of all three ipsilateral mediastinal compartments including the infr
acarinal region. Additional contralateral mediastinal lymph node exploratio
n may not be justified. A direct therapeutic effect of mediastinal lymph no
de removal may be attributed to the prevention of local tumor growth. Howev
er, its overall prognostic significance remains unclear because it must be
assumed that proven tumor within the mediastinal lymph nodes reflects the s
tate of tumor generalization that may not be cured by localized therapeutic
means. New systemic interventions are clearly warranted to significantly i
mprove prognosis in stage II and III lung cancer patients.